These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7820186)

  • 1. Improved delivery through biological membranes. LXI: Design, synthesis, and evaluation of a lipolol-based intradermal drug targeting system for 5-fluorouracil.
    Chikhale PJ; Marvanyos E; Bodor NS
    Cancer Biother; 1994; 9(3):245-52. PubMed ID: 7820186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Alkylcarbonyloxymethyl prodrugs of 5-fluorouracil (5-FU): synthesis, physicochemical properties, and topical delivery of 5-FU.
    Taylor HE; Sloan KB
    J Pharm Sci; 1998 Jan; 87(1):15-20. PubMed ID: 9452962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake.
    Wenande E; Olesen UH; Nielsen MM; Janfelt C; Hansen SH; Anderson RR; Haedersdal M
    Expert Opin Drug Deliv; 2017 Mar; 14(3):307-317. PubMed ID: 27835937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
    Safwat MA; Soliman GM; Sayed D; Attia MA
    Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
    Puri R; Jain S
    Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs.
    Roberts WJ; Sloan KB
    J Pharm Sci; 2003 May; 92(5):1028-36. PubMed ID: 12712422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of the stratum corneum and dermis of the skin on the percutaneous absorption of fluorouracil delivered through skin patch].
    Li GF; Chen JH; Kamiyama F; Yamamoto A; Chen ZL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):800-2. PubMed ID: 12297435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.
    Beall HD; Sloan KB
    Int J Pharm; 2001 Apr; 217(1-2):127-37. PubMed ID: 11292549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microemulsion-based gel of fluorouracil for transdermal delivery].
    Xiao YY; Liu F; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2010 Nov; 45(11):1440-6. PubMed ID: 21361046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration enhancing effect of tetrahydrogeraniol on the percutaneous absorption of 5-fluorouracil from gels in excised rat skin.
    Hanif RM; Qineng P; Zhan G
    J Control Release; 1998 Nov; 55(2-3):297-302. PubMed ID: 9795085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
    Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
    Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Development and Characterization of Topical Microemulsions of 5-Fluorouracil for the Treatment of Non Melanoma Skin Cancer and its Precursor Lesions.
    Kumar S; Sinha VR
    Anticancer Agents Med Chem; 2015; 16(2):259-68. PubMed ID: 26343142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulations and a prodrug.
    Sherertz EF; Sloan KB; McTiernan RG
    Arch Dermatol Res; 1990; 282(7):463-8. PubMed ID: 2078050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.
    Yoshimasu T; Nishide T; Seo N; Hiroi A; Ohtani T; Uede K; Furukawa F
    Clin Exp Immunol; 2004 May; 136(2):245-54. PubMed ID: 15086387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdialysis sampling for the investigation of dermal drug transport.
    Ault JM; Lunte CE; Meltzer NM; Riley CM
    Pharm Res; 1992 Oct; 9(10):1256-61. PubMed ID: 1448422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of 5-FU in skin samples for the development of new delivery systems for topical cancer treatment.
    Petrilli R; Eloy JO; Paschoal JAR; Lopez RFV
    Pharmazie; 2018 Mar; 73(3):133-138. PubMed ID: 29544559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel brain targeted 5-fU derivative with potential antitumor efficiency and decreased acute toxicity: synthesis, in vitro and in vivo evaluation.
    Chen H; Wu W; Li Y; Gong T; Sun X; Zhang Z
    Pharmazie; 2014 Apr; 69(4):271-6. PubMed ID: 24791590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment.
    Fang JY; Hung CF; Fang YP; Chan TF
    Int J Pharm; 2004 Feb; 270(1-2):241-9. PubMed ID: 14726139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil.
    Lee WR; Shen SC; Wang KH; Hu CH; Fang JY
    J Pharm Sci; 2002 Jul; 91(7):1613-26. PubMed ID: 12115823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Water in oil microemulsions containing NaCl for transdermal delivery of fluorouracil].
    Xiao YY; Liu F; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2011 Jun; 46(6):720-6. PubMed ID: 21882535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.